Farthing C et al. |
Azithromycin for cerebral toxoplasmosis. |
1992 |
Lancet |
pmid:1346707
|
Chave JP et al. |
Once-a-week azithromycin in AIDS patients: tolerability, kinetics, and effects on zidovudine disposition. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324635
|
Derouin F et al. |
Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324642
|
Pajukanta R et al. |
In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329617
|
Bonnet M and Van der Auwera P |
In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329619
|
Brown BA et al. |
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1317144
|
Kobrehel G et al. |
Synthesis and antibacterial activity of O-methylazithromycin derivatives. |
1992 |
J. Antibiot. |
pmid:1317368
|
Welsh LE et al. |
In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1318677
|
Bahal N and Nahata MC |
The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. |
1992 |
Ann Pharmacother |
pmid:1318761
|
Drew RH and Gallis HA |
Azithromycin--spectrum of activity, pharmacokinetics, and clinical applications. |
1992 |
Pharmacotherapy |
pmid:1319048
|